Dr.
Xavier Fernández-Busquets
Senior Researcher
Ed. Clúster | Baldiri Reixac 10-12 | 08028 | Barcelona
T. +34 932 275 400
Email : xfernandez

ibecbarcelona.eu
Dr. Xavier Fernández-Busquets, senior researcher in IBEC’s Nanobioengineering group, is undertaking research into targeted nanovectors for antimalarial drug delivery with support from IBEC and the Centre de Recerca en Salut International de Barcelona (CRESIB) under an official agreement signed in 2010. This proposed the establishment of a mixed unit of personnel from both institutes aimed at developing diagnostic and therapeutic nanomedicine-based systems to be applied to malaria.
In 2011 this initiative was favourably reviewed and will continue for another three years.
For more details please visit the group page at the CRESIB website.
Publications
-
Valle-Delgado, J., Urbán, P. & Fernández-Busquets, X. (2012). Demonstration of specific binding of heparin to Plasmodium falciparum-infected vs non-infected red blood cells by single-molecule force spectroscopy. Nanoscale.
-
Moles, E., Urbán, P., Marques, J., Valle-Delgado, J. J., Díez, A., Prieto, B. & Fernández-Busquets, X (2012). Towards a magic bullet against malaria: Paul Ehrlich revisited. In 3rd International Conference on Nanotechnology: Fundamentals and Applications. International ASET Inc..
-
Mir Llorente, M., Tahirbegi, B., Valle-Delgado, J., Fernández-Busquets, X. & Samitier, J. (2012). In vitro study of magnetite-amyloid β complex formation. Nanomedicine: Nanotechnology, Biology and Medicine, 8(6), 974-980.
-
Villar-Piqué, A., de Groot, N. S., Sabaté, R., Acebrón, S. P., Celaya, G., Fernández-Busquets, X., Muga, A. & Ventura, S. (2012). The effect of amyloidogenic peptides on bacterial aging correlates with their intrinsic aggregation propensity. Journal of Molecular Biology, 421(2-3), 270-281.
-
Urbán, P., Valle-Delgado, J., Moles, E., Marques, J., Díez, C. & Fernández-Busquets, X. (2012). Nanotools for the Delivery of Antimicrobial Peptides. Current Drug Targets, 13(9), 1158-1172.
[View All]